Announce Date | 08/05/2025 |
EPS Normalized Actual | $0.01 (Beat by $0.08) |
EPS GAAP Actual | $0.01 (Beat by $0.08) |
Revenue Actual | $0.236194B |
Revenue Surprise | Beat by $236.194M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.73 |
EPS GAAP Estimate | $-0.73 |
Revenue Estimate | $0.13815B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 3.485 | 12.74 | 3.21022 | 3.77796 | 1 |
Dec 2028 | 3.28 | 13.53 | 3.21776 | 3.33716 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.06 | -0.08 | 0.236194B | 10.36% | -5.46M |
FQ1 2025 (Mar 2025) | 2.18 | -0.06 | 0.494284B | 12.3% | -8.17M |
FQ4 2024 (Dec 2024) | 1.16 | 1.16 | 0.370876B | 4.09% | 370.88M |
FQ3 2024 (Sep 2024) | -0.71 | -0.71 | 0.136934B | -3.32% | 136.93M |
FQ2 2024 (Jun 2024) | -0.0728 | -0.0728 | 0.211714B | -12.35% | 211.71M |
FQ1 2024 (Mar 2024) | 1.69 | 1.69 | 0.43347B | -6.68% | 433.47M |
FQ4 2023 (Dec 2023) | 1.19 | 1.19 | 0.355714B | 88.24% | 355.71M |
FQ3 2023 (Sep 2023) | -0.65 | -0.65 | 0.141479B | 96.86% | 141.48M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.73
Consensus Revenue Estimates
0.13815B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.009 | -- | 1.88248 | 2.16827 | 1 |
FQ3 2027 (Sep 2027) | -1.6059 | -- | -1.73321 | -1.50477 | 1 |
FQ2 2027 (Jun 2027) | 0.1089 | -- | 0.10204 | 0.11753 | 1 |
FQ1 2027 (Mar 2027) | 2.71 | -- | 2.53933 | 2.92484 | 1 |
FQ4 2026 (Dec 2026) | 1.43 | -- | 1.30848 | 1.54574 | 1 |
FQ3 2026 (Sep 2026) | -0.74 | -- | -0.79989 | -0.67712 | 1 |
FQ2 2026 (Jun 2026) | 0.03 | 300 | 0.02745064 | 0.0324281 | 1 |
FQ1 2026 (Mar 2026) | 2.33 | 6.44 | 2.132 | 2.51858 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.48B | -- | 0.45B | 0.51B | 1 |
FQ3 2027 (Sep 2027) | 0.18B | -- | 0.17B | 0.19B | 1 |
FQ2 2027 (Jun 2027) | 0.29B | -- | 0.27B | 0.3B | 1 |
FQ1 2027 (Mar 2027) | 0.62B | -- | 0.59B | 0.65B | 1 |
FQ4 2026 (Dec 2026) | 0.42B | -- | 0.39B | 0.44B | 1 |
FQ3 2026 (Sep 2026) | 0.15B | -- | 0.14B | 0.16B | 1 |
FQ2 2026 (Jun 2026) | 0.26B | 8.45 | 0.24B | 0.27B | 1 |
FQ1 2026 (Mar 2026) | 0.51B | 2.12 | 0.47B | 0.54B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.02 | -0.06 | -0.08 | 133.33% |
FQ1 2025 (Mar 2025) | 2.24 | 2.18 | -0.06 | -2.75% |
FQ4 2024 (Dec 2024) | 1.16 | 1.16 | 100% | |
FQ3 2024 (Sep 2024) | -0.71 | -0.71 | 100% | |
FQ2 2024 (Jun 2024) | -0.0728 | -0.0728 | 100% | |
FQ1 2024 (Mar 2024) | 1.69 | 1.69 | 100% | |
FQ4 2023 (Dec 2023) | 1.19 | 1.19 | 100% | |
FQ3 2023 (Sep 2023) | -0.65 | -0.65 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.24B | $0.24B | $-5.46M | -2.31% |
FQ1 2025 (Mar 2025) | $0.5B | $0.49B | $-8.17M | -1.65% |
FQ4 2024 (Dec 2024) | $0B | $0.37B | $370.88M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.14B | $136.93M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.21B | $211.71M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.43B | $433.47M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.36B | $355.71M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.14B | $141.48M | 100% |